Trial intelligence / Profile preview

Ferric carboxymaltose versus iron sucrose in women with iron deficiency anemia

ISRCTN14484575Phase 4Completed

Sponsor
University of Kashmir
Start
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in iron deficiency anemia (IDA) comparing Ferric carboxymaltose with Iron sucrose (2 arms). Primary endpoints: Effectiveness and safety based on laboratory biomarkers at week 4, Drug-related problems at week 4 and 1 more. Started Jul 2015; status: completed.

02

Drugs

ferric carboxymaltoseiron sucrose
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on ISRCTN14484575.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN14484575.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call